194 related articles for article (PubMed ID: 27447700)
1. National Trends in the Surgical Treatment of Non-advanced Medullary Thyroid Cancer (MTC): An Evaluation of Adherence with the 2009 American Thyroid Association Guidelines.
Chang EHE; Lutfi W; Feinglass J; Reiher AE; Moo-Young T; Bhayani MK
World J Surg; 2016 Dec; 40(12):2930-2940. PubMed ID: 27447700
[TBL] [Abstract][Full Text] [Related]
2. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
Panigrahi B; Roman SA; Sosa JA
Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
[TBL] [Abstract][Full Text] [Related]
3. Improved Adherence to ATA Medullary Thyroid Cancer Treatment Guidelines.
McMullin JL; Sharma J; Gillespie T; Patel SG; Weber CJ; Saunders ND
Ann Surg Oncol; 2023 Nov; 30(12):7165-7171. PubMed ID: 36367629
[TBL] [Abstract][Full Text] [Related]
4. Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?
Grubbs EG; Waguespack SG; Rich TA; Xing Y; Ying AK; Evans DB; Lee JE; Perrier ND
Surgery; 2010 Dec; 148(6):1302-9; discussion 1309-10. PubMed ID: 21134565
[TBL] [Abstract][Full Text] [Related]
5. Fewer cancer reoperations for medullary thyroid cancer after initial surgery according to ATA guidelines.
Verbeek HH; Meijer JA; Zandee WT; Kramp KH; Sluiter WJ; Smit JW; Kievit J; Links TP; Plukker JT
Ann Surg Oncol; 2015 Apr; 22(4):1207-13. PubMed ID: 25316487
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of medullary thyroid cancer: which guidelines should we follow?
Bowen A; Mani N; Penney S; Loughran S; Yap B
J Laryngol Otol; 2015 May; 129(5):478-83. PubMed ID: 25994382
[TBL] [Abstract][Full Text] [Related]
7. Barriers to the recognition of medullary thyroid carcinoma on FNA: Implications relevant to the new American Thyroid Association guidelines.
Dyhdalo KS; Chute DJ
Cancer Cytopathol; 2018 Jun; 126(6):397-405. PubMed ID: 29579362
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of medullary thyroid carcinoma.
Konstantinidis A; Stang M; Roman SA; Sosa JA
Updates Surg; 2017 Jun; 69(2):151-160. PubMed ID: 28409442
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic characteristics of medullary thyroid carcinoma according to nodule size: application of the Korean Thyroid Imaging Reporting and Data System and American Thyroid Association guidelines.
Hahn SY; Shin JH; Oh YL; Park KW
Acta Radiol; 2021 Apr; 62(4):474-482. PubMed ID: 32493032
[TBL] [Abstract][Full Text] [Related]
10. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
11. Risk and survival of patients with medullary thyroid cancer: National perspective.
Al-Qurayshi Z; Khadra H; Chang K; Pagedar N; Randolph GW; Kandil E
Oral Oncol; 2018 Aug; 83():59-63. PubMed ID: 30098780
[TBL] [Abstract][Full Text] [Related]
12. High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer.
Chen L; Sun W; Qian K; Guo K; Sun T; Wu YI; Wang Z
Endocr Pract; 2020 Jul; 26(7):738-747. PubMed ID: 33471642
[TBL] [Abstract][Full Text] [Related]
13. Demographic and socioeconomic factors predictive of compliance with American Thyroid Association guidelines for the treatment for advanced papillary thyroid carcinoma.
Wenaas AE; Nagy CZ; Yiu Y; Xu L; Horter K; Zevallos JP
Head Neck; 2015 Dec; 37(12):1776-80. PubMed ID: 24986680
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
Kuo EJ; Sho S; Li N; Zanocco KA; Yeh MW; Livhits MJ
JAMA Surg; 2018 Jan; 153(1):52-59. PubMed ID: 28973144
[TBL] [Abstract][Full Text] [Related]
15. Guideline Adherence and Practice Patterns in the Management of Medullary Thyroid Cancer.
Frisco NA; Gunn AH; Wang F; Stang MT; Kazaure HS; Scheri RP
J Surg Res; 2023 Jan; 281():214-222. PubMed ID: 36191377
[TBL] [Abstract][Full Text] [Related]
16. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
[TBL] [Abstract][Full Text] [Related]
17. External Beam Radiotherapy for Medullary Thyroid Cancer Following Total or Near-Total Thyroidectomy.
Jin M; Megwalu UC; Noel JE
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):97-103. PubMed ID: 32746731
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
19. Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.
Ito Y; Miyauchi A; Kihara M; Higashiiyama T; Fukushima M; Miya A
World J Surg; 2018 Dec; 42(12):3954-3966. PubMed ID: 30051240
[TBL] [Abstract][Full Text] [Related]
20. CALCITONIN SECRETORY INDEX AND UNSUSPECTED NODAL DISEASE IN MEDULLARY THYROID CARCINOMA.
Filimon S; Payne RJ; Black MJ; Hier MP; Mlynarek AM; Forest VI; Tamilia M
Endocr Pract; 2018 May; 24(5):460-467. PubMed ID: 29847167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]